Safety of probiotics and synbiotics in children under 18 years of age. (Q41159908)

27 September 2017

title

Safety of probiotics and synbiotics in children under 18 years of age. (English)

1 reference

27 September 2017

0 references

M van den Nieuwboer

1

1 reference

27 September 2017

R J Brummer

2

1 reference

27 September 2017

F Guarner

3

1 reference

27 September 2017

L Morelli

4

1 reference

27 September 2017

M Cabana

5

1 reference

27 September 2017

E Claassen

6

1 reference

27 September 2017

publication date

25 March 2015

1 reference

27 September 2017

1 reference

27 September 2017

volume

6

1 reference

27 September 2017

issue

5

1 reference

27 September 2017

page(s)

615-630

1 reference

Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Probiotics for treating acute infectious diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Ecological control of the gastrointestinal tract. The role of probiotic flora

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Long-term administration of probiotics to asymptomatic pre-school children for either the eradication or the prevention of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Functions of intestinal microflora in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Probiotics have clinical, microbiologic, and immunologic efficacy in acute infectious diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Reduction of salivary mutans streptococci in orthodontic patients during daily consumption of yoghurt containing probiotic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Intestinal absorption and permeability in paediatric short-bowel syndrome: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Probiotic lactic acid bacteria in the gastro-intestinal tract: health benefits, safety and mode of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Exposure to environmental microorganisms and childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: a prospective, randomized, double-blind, placebo-controlled, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: a randomized, controlled, open label study

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Probiotics to adolescents with obesity: effects on inflammation and metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Mechanisms of disease: the hygiene hypothesis revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Probiotics for preventing acute upper respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Probiotics in neonatology

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Control of pathogens and pathobionts by the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double-blind efficacy randomised controlled trial in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Antibiotic Resistance and Molecular Characterization of Probiotic and ClinicalLactobacillusStrains in Relation to Safety Aspects of Probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Evaluation of efficacy of probiotics in prevention of candida colonization in a PICU-a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Effect of probiotics on allergic rhinitis in Df, Dp or dust-sensitive children: a randomized double blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

A case of D-lactic acid encephalopathy associated with use of probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

The effect of Lactobacillus GG on acute diarrheal illness in the pediatric emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Specific probiotics alleviate allergic rhinitis during the birch pollen season

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Randomised clinical trial: efficacy of a new synbiotic formulation containing Lactobacillus paracasei B21060 plus arabinogalactan and xilooligosaccharides in children with acute diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Effect of probiotic supplementation on immunoglobulins, isoagglutinins and antibody response in children of low socio-economic status.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Role of probiotics in short bowel syndrome in infants and children--a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Lactobacillus acidophilus and Bifidobacterium bifidum stored at ambient temperature are effective in the treatment of acute diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Demonstration of safety of probiotics -- a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

An update on the use and investigation of probiotics in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Tolerance, safety, and effect on the faecal microbiota of an enteral formula supplemented with pre- and probiotics in critically ill children

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Salivary mutans streptococci and lactobacilli modulations in young children on consumption of probiotic ice-cream containing Bifidobacterium lactis Bb12 and Lactobacillus acidophilus La5.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Hay fever, hygiene, and household size

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slum

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Novel probiotic Enterococcus faecium IS-27526 supplementation increased total salivary sIgA level and bodyweight of pre-school children: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Fermented milk containing Bifidobacterium lactis DN-173 010 in childhood constipation: a randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

The administration of probiotics and synbiotics in immune compromised adults: is it safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Probiotic and synbiotic safety in infants under two years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Probiotics, prebiotics, and synbiotics: gut and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

The role of prebiotics and probiotics in prevention and treatment of childhood infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Lactobacillus salivarius plus fructo-oligosaccharide is superior to fructo-oligosaccharide alone for treating children with moderate to severe atopic dermatitis: a double-blind, randomized, clinical trial of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: A randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0157

21 January 2018

Identifiers

DOI

10.3920/BM2014.0157

1 reference

27 September 2017

1 reference